Celldex Therapeutics
CLDX
#4701
Rank
HK$15.23 B
Marketcap
HK$229.25
Share price
-0.51%
Change (1 day)
13.01%
Change (1 year)

Celldex Therapeutics (CLDX) - Net assets

Net assets on the balance sheet as of September 2025 : HK$4.65 Billion

According to Celldex Therapeutics's latest financial reports the company has HK$4.65 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Celldex Therapeutics - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$HK$5.79 B73.02%
2023-12-31$HK$3.35 B31.51%
2022-12-31$HK$2.54 B-22.08%
2021-12-31$HK$3.27 B101.54%
2020-12-31$HK$1.62 B121.63%
2019-12-31$HK$0.73 B-24.62%
2018-12-31$HK$0.97 B-47.39%
2017-12-31$HK$1.84 B-10.28%
2016-12-31$HK$2.05 B-8.46%
2015-12-31$HK$2.24 B36.96%
2014-12-31$HK$1.64 B-33.8%
2013-12-31$HK$2.47 B234.04%
2012-12-31$HK$0.74 B39.08%
2011-12-31$HK$0.53 B-8.86%
2010-12-31$HK$0.58 B2.39%
2009-12-31$HK$0.57 B308.17%
2008-12-31$HK$0.14 B-1687.81%
2007-12-31$-HK$8.83 Million-152.51%
2006-12-31$HK$16.8 M-89.62%
2005-12-31$HK$0.16 B-45.74%
2004-12-31$HK$0.29 B37.92%
2003-12-31$HK$0.21 B-11.47%
2002-12-31$HK$0.24 B-30.75%
2001-12-31$HK$0.35 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Seagen
SGEN
HK$19.85 B 326.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
-HK$2.19 Billion-146.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
HK$4.53 B-2.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$74.87 B 1,507.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$724.69 B 15,458.45%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$164.84 B 3,438.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
HK$21.7 M-99.53%๐Ÿ‡บ๐Ÿ‡ธ USA